Detalhe da pesquisa
1.
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy.
Allergy
; 79(2): 485-498, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112286
2.
Comparison of house dust mite sensitization profiles in allergic adults from Canada, Europe, South Africa and USA.
Allergy
; 76(7): 2177-2188, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33484161
3.
Investigating Immune Gene Signatures in Peripheral Blood from Subjects with Allergic Rhinitis Undergoing Nasal Allergen Challenge.
J Immunol
; 199(10): 3395-3405, 2017 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29046347
4.
Immunological changes in peripheral blood following nasal allergen challenge in subjects with allergic rhinitis pre- and post-peptide immunotherapy: An open-label clinical study.
Allergy
; 76(6): 1907-1911, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33320968
5.
Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study.
J Allergy Clin Immunol
; 131(1): 103-9.e1-7, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22981787
6.
The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): verification of nasal allergen challenge procedures in a study utilizing an investigational immunotherapy for cat allergy.
Clin Transl Allergy
; 8: 15, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29682277
7.
Colloidal characteristics and formulation of pure protein particulate vaccines.
J Pharm Pharmacol
; 64(10): 1386-93, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22943169